CME Group Reports Record International Trading Volume for 2025

CME
January 09, 2026

CME Group disclosed that its international average daily volume (ADV) for 2025 reached a record 8.4 million contracts, an 8 % increase from the 7.8 million contracts reported in 2024. The jump reflects a broad‑based surge across all six asset classes, with metals up 37 %, equity index up 20 %, energy up 11 %, agricultural up 9 % and interest‑rate products up 2 %.

The record ADV is part of a steady upward trajectory: 6.8 million contracts in 2023, 7.8 million in 2024, and 8.4 million in 2025. Globally, the ADV climbed to 28.1 million contracts, up 6 % from 2024, while interest‑rate ADV rose to 14.2 million contracts, a 4 % increase, and metals ADV grew 34 % year‑over‑year. These gains underscore CME’s expanding global footprint and its ability to attract liquidity across all regions and asset classes.

Regionally, the EMEA market contributed 6.1 million contracts, up 6 % from 2024, and the APAC market added 1.9 million contracts, up 13 %. The growth in these key markets is driven by persistent economic and geopolitical uncertainty, which has heightened demand for risk‑management tools and deep, around‑the‑clock liquidity. "Amid persistent economic and geopolitical uncertainty in 2025, clients outside the United States relied on the proven strength of our global benchmarks and deep, around‑the‑clock liquidity," said Julie Winkler, Senior Managing Director and Chief Commercial Officer. "Risk management remains essential for 2026, and we are committed to providing clients with the tools they need to efficiently navigate any market environment."

The record international ADV signals strong demand for CME’s derivatives products, diversifies revenue streams, and reduces reliance on the U.S. market. It also reinforces the company’s high‑margin business model, as the deep liquidity and network effect enable CME to capture a larger share of global trading activity. The milestone aligns with CME’s strategic focus on global expansion, technological advancement, and robust clearing house operations, positioning the firm to capitalize on continued volatility and risk‑management needs worldwide.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.